GUIAS HIPERTENSION ARTERIAL.indb - Scc

Revista Colombiana de Cardiología
Febrero 2007
18. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left
ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;
57: 450-458.
19. Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB. Two dimensional echocardiographic
calculation of left ventricular mass as recommended by the
American Society of Echocardiography. J Am Soc Echocardiogr 1996; 9:
119-128.
20. Hansson L, Zanchetti A, Carruthers SG, et al, for the HOT Study Group. Effects
of intensive blood-pressure lowering and low-dose aspirin in patients with
hypertension: principal results of the Hypertension Optimal Treatment (HOT)
randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762.
Vol. 13 Suplemento 1
ISSN 0120-5633
283
21. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications
of echocardiographically determined left ventricular mass in the Framingham
Heart Study. N Engl J Med 1990; 322: 1561-1566.
22. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic
role of left ventricular hypertrophy in patients with or without coronary artery
disease. Ann Intern Med 1992; 117: 831-836.
23. Koren MJ, Ulin RJ, Koren AT, Laragh JH, Devereux RB. Left ventricular mass
change during treatment and outcome in patients with essential hypertension.
Am J Hypertens 2002; 15: 1021-1028.
24. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis
of the effects of treatment on left ventricular mass in essential hypertension. Am
J Med 2003; 115: 41-46.